REQUEST A DEMO
Total
USD $0.00
Search more companies

Avlaan Pharmaceutical Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Avlaan Pharmaceutical Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Avlaan Pharmaceutical Private Limited is an unlisted company, incorporated on 04/12/2014. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U24100TN2014PTC098319 and registration number is 098319. The company is a trade company, it is engaged in wholesale trading.

Legal Address
207, Dbs House, 31A, Cathedral Garden Road, Nungambakkam,
Chennai; Tamil Nadu; Postal Code: 600034

Contact Details: Purchase the Avlaan Pharmaceutical Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Avlaan Pharmaceutical Private Limited report to view the information.
Registered Capital:
Purchase the Avlaan Pharmaceutical Private Limited report to view the information.
Incorporation Date:
December 04, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Avlaan Pharmaceutical Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
27.77%
Total operating revenue
27.92%
Operating profit (EBIT)
-53.55%
EBITDA
-51.95%
Net Profit (Loss) for the Period
-52.89%
Total assets
36.53%
Total equity
10.39%
Operating Profit Margin (ROS)
-6.51%
Net Profit Margin
-4.75%
Return on Equity (ROE)
-12.63%
Quick Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?